Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $31.54 in the prior trading day, MBX Biosciences Inc (NASDAQ: MBX) closed at $30.55, down -3.14%. In other words, the price has decreased by -$3.14 from its previous closing price. On the day, 0.56 million shares were traded. MBX stock price reached its highest trading level at $31.61 during the session, while it also had its lowest trading level at $29.63.
Ratios:
Our goal is to gain a better understanding of MBX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 32.95 and its Current Ratio is at 32.95. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on December 04, 2025, initiated with a Sell rating and assigned the stock a target price of $18.
On October 15, 2025, Truist started tracking the stock assigning a Buy rating and target price of $50.Truist initiated its Buy rating on October 15, 2025, with a $50 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 20 ’25 when Hawryluk P. Kent bought 20,000 shares for $13.64 per share. The transaction valued at 272,790 led to the insider holds 468,277 shares of the business.
Hoerter Steven L. bought 20,000 shares of MBX for $264,984 on Oct 17 ’25. The Director now owns 20,000 shares after completing the transaction at $13.25 per share. On Sep 26 ’25, another insider, Heron Patrick J, who serves as the Director of the company, bought 666,666 shares for $18.00 each. As a result, the insider paid 11,999,988 and bolstered with 5,219,440 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBX now has a Market Capitalization of 1371765376 and an Enterprise Value of 980715328.
Stock Price History:
The Beta on a monthly basis for MBX is 0.87, which has changed by 0.87653565 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, MBX has reached a high of $35.55, while it has fallen to a 52-week low of $4.81. The 50-Day Moving Average of the stock is 12.74%, while the 200-Day Moving Average is calculated to be 94.51%.
Shares Statistics:
The stock has traded on average 861.77K shares per day over the past 3-months and 910760 shares per day over the last 10 days, according to various share statistics. A total of 44.72M shares are outstanding, with a floating share count of 26.48M. Insiders hold about 41.02% of the company’s shares, while institutions hold 68.73% stake in the company. Shares short for MBX as of 1765756800 were 3611905 with a Short Ratio of 4.19, compared to 1763078400 on 4629382. Therefore, it implies a Short% of Shares Outstanding of 3611905 and a Short% of Float of 12.85.
Earnings Estimates
The dynamic stock of MBX Biosciences Inc (MBX) is currently attracting attention from 6.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.72, with high estimates of -$0.63 and low estimates of -$0.9.
Analysts are recommending an EPS of between -$2.21 and -$2.82 for the fiscal current year, implying an average EPS of -$2.54. EPS for the following year is -$3.19, with 7.0 analysts recommending between -$2.39 and -$4.58.
